When did biktarvy come out?

When did Biktarvy first get approved and reach the market?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) was approved by the U.S. Food and Drug Administration (FDA) on February 7, 2018, and that approval is what marked its “come out” date in the U.S. market. [1]

What does that approval date mean for real-world availability?

In practice, the FDA approval date is the key milestone for when Biktarvy could be marketed in the U.S.; patients typically gained access shortly after through prescriptions and standard pharmacy supply once distribution ramped up. The FDA approval itself is the earliest documented public launch marker. [1]

Source

1. DrugPatentWatch.com – Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) approval info